Rules and Procedures for IMI2 Calls for proposals. Magali Poinot, IMI Legal Manager Webinar FFG Austria 16 July 2015

Transcription

1 Rules and Procedures for IMI2 Calls for proposals Magali Poinot, IMI Legal Manager Webinar FFG Austria 16 July 2015

2 Outline 1. Participation rules 2. Funding rules 3. Intellectual property rules 4. From Call to grant award 5. Tips for success 6. More information

3 A single set of rules COSME etc. EU Financial Regulation Specific rules for participation Covering all H2020 research and innovation actions Adaptability where needed: Entities eligible for funding IP

4 Participation rules

5 Attracting stakeholders Any legal entity regardless its place of establishment carrying out work relevant to the Call objectives may be part of applicant consortia But not all participating entities are eligible for funding

6 Who is eligible for funding? Academic institutions Small & medium-sized enterprises (SMEs) Mid-sized enterprises ( 500m) Non-profit organisations e.g. research organisations, patient organisations, NGOs, public bodies, intergovernmental organisations etc. Established in: EU Member State Associated Country Other countries: No funding unless - participation deemed essential by IMI for carrying out the action - Annual Work Plan / Calls documents

7 Expected consortia Stage 1 - Short Proposals (RIA) Consortia consisting of: A minimum of three independent IMI fundable legal entities - each established in a different Member State or an associated country - carrying out activities relevant for achieving the project objectives additional legal entities carrying out activities relevant for achieving the project objectives

8 Funding rules

9 One single funding rate per project NEW! One project = One rate For all beneficiaries and all activities Defined in the annual work plan/call documents: Up to 100% of the eligible costs but limited to a maximum of 70% for innovation projects (exception for non-profit organisations - maximum of 100%) Considering accounting and management principles

10 One single indirect cost model New! Single model: 25% Flat Rate

11 A more attractive funding model An example Majority of beneficiaries Flat-rate 20% (or actual) Direct costs Indirect costs Total costs % IMI1 contribution IMI1 contribution % Direct costs Indirect costs Total costs % IMI2 IMI2 contribution contribution 100/25 Funding % 125

12 EFPIA and Associated Partners contribution EFPIA companies Other industries and partners (= Associated Partners to IMI2) New! In-kind (actual direct and indirect costs or average FTE) + cash contributions Based on the usual management principles and accounting practices Contributions from affiliated entities as part of in-kind When relevant to IMI2 objectives: up to 30% non-eu in-kind contribution

13 IMI s Intellectual Property (IP) rules

14 One policy for multiple interests Support to industry Incentive to participate Dissemination of information flexibility + trusted party Freedom of access Compensation for IP

15 Start End Background vs. Results Implementation of the action Results Background identification Access rights flexibility + trusted party Access rights Sideground Generated during the action but outside of its objectives and not needed for implementation or Research Use

16 Ownership of results Results belong to the beneficiary who generated it Possible transfer flexibility of ownership - within the consortium + to affiliates and purchasers without trusted prior notification - on case-by-case party basis Joint ownership regime

17 Research Use vs. Exploitation Research Use Use of results or background necessary to use the results for all purposes other than for completing the action or for direct exploitation Based on previous experience Direct exploitation to develop for commercialisation or to commercialise the results

18 Access Rights conditions Access rights granted by a beneficiary to/on Background (necessary and identified) Results Sideground Beneficiaries for completion of the action Royalty-free Royalty-free N.A. Beneficiaries and affiliates for Research Use Fair & reasonable terms for background needed for using the results Fair & reasonable terms N.A. Third Parties for Research Use after the action Fair & reasonable terms for background needed for using the results Fair & reasonable terms N.A. Beneficiaries and affiliates or Third Parties for Direct Exploitation To be negotiated To be negotiated N.A. Based on previous experience

19 Dissemination modalities Each beneficiary has the obligation to disseminate its own results: As soon as reasonably practicable NEW for publications: Open access is mandatory Mandatory mention to IMI support & Partners in-kind contribution in patent applications / all communications

20 From Call to grant award

21 Evaluation Evaluation Typical IMI project life cycle Topic definition Stage 1 Stage 2 Grant award Industry Assoc partners Academics Mid-size enterprises SMEs Hospitals Regulators Patients organisations Applicant consortium Industry APs Identification of topics and willingness to collaborate Applicant consortia submit short proposals Full consortium submits full proposal Project Agreement Grant Agreement Call launch Merger: applicants & industry Finalisation Project launch!

22 A single set of evaluation criteria Standard criteria Excellence Impact Quality & efficiency Two-stage evaluation: only Excellence and Impact considered at stage 1 Thresholds and weighting in the Call documents Minimum of 3 independent experts (possibility of 2 in a two-stage process) NEW! Each proposal evaluated as it is, not as what could be

23 Tips for success

24 Common Mistakes Admissibility/Eligibility criteria not met: submission deadline missed proposal out of scope (if you have doubts on how to respond to the Call contact us) submitted text does not respect the proposal template (sometimes received even slides!) A minimum of three legal entities (RIA)

25 Common Mistakes The proposal does not address all the objectives (in some cases proposals have nothing to do with the topic!) Applicants do not have the capabilities to address all of the objectives or there is redundancy between partners A proposal is scientifically excellent but will have limited impact Ethical issues not addressed

26 Tips Read all the Call-relevant material that is provided on the IMI website Understand IMI 2 rules and respect them If in doubt, ask a member of the Programme Office Your proposal should provide reviewers with all the information requested to allow them to evaluate it Start working early (pre-materials available before) Finalise and submit your submission

27 Submitting a proposal

28 Partner Search Tool

29 More information

30 Reference documents H2020 Rules for Participation IPR section: Article 1.3.c and Articles 41 to 49 IMI2 Delegated Regulation IPR section: Articles 2 to 7 IMI2 model Grant Agreement (revised January 2015) IPR section: Articles 23a to 31 IMI2 annotated Grant Agreement (soon)

31 Stay in touch Visit our website Sign up to our newsletter bit.ly/iminewsletter Follow us on Join our LinkedIn group bit.ly/linkedinimi us

32 Your contact points At the IMI Programme Office General queries: IP queries: Local contacts IMI States Representatives Group: bit.ly/imisrg Horizon 2020 Health National Contact Points: bit.ly/h2020_ncps

33 Thank you!